The tragic history of AIDS in the hemophilia population, 1982–1984
Interventions to prevent venous thrombosis after air travel, are they necessary? Yes
Interventions to prevent venous thrombosis after air travel
The potential role of antiplatelet agents in modulating inflammatory markers in atherothrombosis
Nucleotide receptor signaling in platelets
Is protein C inhibitor antithrombotic and protective in pulmonary hypertension?
Protective role of protein C inhibitor in monocrotaline-induced pulmonary hypertension
Local administration of recombinant human antithrombin in a mouse model of peritoneal sepsis
Anticoagulant and anti-inflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis
Unraveling the immunologic response in thrombotic thrombocytopenic purpura
Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura
Anticoagulation therapy after recent bleeding
Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome
Use of preventive measures for air travel-related venous thrombosis in professionals who attend medical conferences
Prevalence of immune thrombocytopenia
Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery
Tissue factor serum levels and the risk of future coronary artery disease in apparently healthy men and women
Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy
Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke
Peptidomimetic inhibitors for activated protein C
Low protein Z levels and risk of occurrence of deep vein thrombosis
Platelet nitric oxide synthase is activated by tyrosine dephosphorylation
Characterization of a patient with glycoprotein (GP) VI deficiency possessing neither anti-GPVI autoantibody nor genetic aberration
Heparanase induces tissue factor expression in vascular endothelial and cancer cells
Histamine differentially interacts with tumor necrosis factor-α and thrombin in endothelial tissue factor induction
Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome
Characterization of rat thrombin-activatable fibrinolysis inhibitor (TAFI) – a comparative study assessing the biological equivalence of rat, murine and human TAFI
Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression
Flow-based assays for global assessment of hemostasis. Part 1
Effect of protein C and activated protein C on alveolar fibrin deposition and turnover in a piglet model of septic shock
Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction
Postpartum residual venous obstruction of the lower limbs in the matched case–control ‘NOHA first’ study on miscarriage
Platelet activation in subjects carrying factor V Leiden or factor II A20210 mutations
Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors
Acute effect of smoking and of 2 weeks of folate substitution on hemostasis and homocysteine in healthy chronic smokers
Fixed-dose low-molecular-weight heparin, bemiparin, in the long-term treatment of venous thromboembolism in patients with transient risk factors in standard clinical practice
Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin
Endotoxemia enhances circulating endothelial cells in humans
The von Willebrand disease prophylaxis network
Endogenous tissue-type plasminogen activator and cardioembolic brain infarct subtype
Between-batch variation of calibrator activity can significantly influence fluorogenic measurement of thrombin generation
A head-to-head comparison between the VerifyNow® P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention
CORRIGENDUM
ANNOUNCEMENTS